This Article Full Text Full Text (PDF) Supplemental Data All Versions of this Article: 21/5/1095    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager NURSA Molecule Pages Link Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bassett, J. H. D. Articles by Williams, G. R. Search for Related Content PubMed PubMed Citation Articles by Bassett, J. H. D. Articles by Williams, G. R.

Thyroid Hormone Excess Rather Than Thyrotropin Deficiency Induces Osteoporosis in Hyperthyroidism

Molecular Endocrinology Group (J.H.D.B., P.J.O., S.S., G.R.W.), Division of Medicine and Medical Research Council (MRC) Clinical Sciences Centre, Imperial College London, Hammersmith Hospital, London W12 0NN, United Kingdom; Institut Nationale de la Santé et de la Recherche Médicale (INSERM) Unité (U) 577 (B.R., O.C.,), Bordeaux F-33000, France; Université Victor Segalen (B.R., O.C.), Bordeaux F-33076, France; Biophysics Oral Growth and Development (A.B., P.G.T.H.), Institute of Dentistry, Bart’s and The London School of Medicine, Queen Mary University of London, London E1 1BB, United Kingdom; Division of Prosthetic Dentistry (P.G.T.H.), Eastman Dental Institute, University College London, London WC1X 8LD, United Kingdom; Thyroid Study Unit (R.E.W.), Department of Medicine, University of Chicago, Chicago, Illinois 60645; INSERM, U831 (J.-P. R.), Lyon, France; Institut Fédératif de Recherche (IFR) 62, Lyon, France; Université Claude Bernard-Lyon I, Faculté de Médecine Laënnec, Lyon, France; INSERM, U890 (L.M.), Saint-Etienne, France; IFR 62, Lyon, France; Université Jean Monnet, Faculté de Médecine, 42023 Saint-Etienne Cedex 2, France; ProSkelia a Galapagos Company (P.C.-L.), 93230 Romainville, France; Laboratoire de Biologie Moléculaire et Cellulaire de l’Ecole Normale Supérieure de Lyon (J.S.), Unité Mixte de Recherche 5665 Centre National de la Recherche Scientifique, Institut National de la Recherche Agronomique 913, Lyon, France

Address all correspondence and requests for reprints to: Graham Williams, Molecular Endocrinology Group, Medical Research Council Clinical Sciences Centre, Clinical Research Building Fifth Floor, Hammersmith Hospital, Du Cane Road, London W12 0NN, United Kingdom. E-mail: graham.williams{at}imperial.ac.uk; or Olivier Chassande, Institut National de la Santé et de la Recherche Médicale Unité 577, Université Victor Segalen Bordeaux 2, Bâtiment 4A, zone Nord, 146, rue Lèo Saignat, 33076 Bordeaux cedex, France. E-mail: Olivier.Chassande{at}bordeaux.inserm.fr.

Thyrotoxicosis is an important but under recognized cause of osteoporosis. Recently, TSH deficiency, rather than thyroid hormone excess, has been suggested as the underlying cause. To investigate the molecular mechanism of osteoporosis in thyroid disease, we characterized the skeleton in mice lacking either thyroid hormone receptor or ß (TR^0/0, TRß^–/–). Remarkably, in the presence of normal circulating thyroid hormone and TSH concentrations, adult TR^0/0 mice had osteosclerosis accompanied by reduced osteoclastic bone resorption, whereas juveniles had delayed endochondral ossification with reduced bone mineral deposition. By contrast, adult TRß^–/– mice with elevated TSH and thyroid hormone levels were osteoporotic with evidence of increased bone resorption, whereas juveniles had advanced ossification with increased bone mineral deposition. Analysis of T₃ target gene expression revealed skeletal hypothyroidism in TR^0/0 mice, but skeletal thyrotoxicosis in TRß^–/– mice. These studies demonstrate that bone loss in thyrotoxicosis is independent of circulating TSH levels and mediated predominantly by TR, thus identifying TR as a novel drug target in the prevention and treatment of osteoporosis.

NURSA Molecule Pages Link:

Nuclear Receptors:   TRα  |  TRβ

Ligands:   Thyroid hormone

This article has been cited by other articles:

				K. A Heemstra, W. M van der Deure, R. P Peeters, N. A Hamdy, M. P Stokkel, E. P Corssmit, J. A Romijn, T. J Visser, and J. W Smit Thyroid hormone independent associations between serum TSH levels and indicators of bone turnover in cured patients with differentiated thyroid carcinoma. Eur. J. Endocrinol., July 1, 2008; 159(1): 69 - 76. [Abstract] [Full Text] [PDF]

				K. Yamoah, A. Brebene, R. Baliram, K. Inagaki, G. Dolios, A. Arabi, R. Majeed, H. Amano, R. Wang, R. Yanagisawa, et al. High-Mobility Group Box Proteins Modulate Tumor Necrosis Factor-{alpha} Expression in Osteoclastogenesis via a Novel Deoxyribonucleic Acid Sequence Mol. Endocrinol., May 1, 2008; 22(5): 1141 - 1153. [Abstract] [Full Text] [PDF]

				L. Sun, S. Vukicevic, R. Baliram, G. Yang, R. Sendak, J. McPherson, L.-L. Zhu, J. Iqbal, R. Latif, A. Natrajan, et al. Intermittent recombinant TSH injections prevent ovariectomy-induced bone loss PNAS, March 18, 2008; 105(11): 4289 - 4294. [Abstract] [Full Text] [PDF]

				J. H. D. Bassett, A. J. Williams, E. Murphy, A. Boyde, P. G. T. Howell, R. Swinhoe, M. Archanco, F. Flamant, J. Samarut, S. Costagliola, et al. A Lack of Thyroid Hormones Rather than Excess Thyrotropin Causes Abnormal Skeletal Development in Hypothyroidism Mol. Endocrinol., February 1, 2008; 22(2): 501 - 512. [Abstract] [Full Text] [PDF]

				P. J. O'Shea, C. J. Guigon, G. R. Williams, and S.-y. Cheng Regulation of Fibroblast Growth Factor Receptor-1 (Fgfr1) by Thyroid Hormone: Identification of a Thyroid Hormone Response Element in the Murine Fgfr1 Promoter Endocrinology, December 1, 2007; 148(12): 5966 - 5976. [Abstract] [Full Text] [PDF]

				E. ABE, L. SUN, J. MECHANICK, J. IQBAL, K. YAMOAH, R. BALIRAM, A. ARABI, B. S. MOONGA, T. F. DAVIES, and M. ZAIDI Bone Loss in Thyroid Disease: Role of Low TSH and High Thyroid Hormone Ann. N.Y. Acad. Sci., November 1, 2007; 1116(1): 383 - 391. [Abstract] [Full Text] [PDF]

				A. Papadimitriou, D. T Papadimitriou, A. Papadopoulou, P. Nicolaidou, and A. Fretzayas Low TSH levels are not associated with osteoporosis in childhood Eur. J. Endocrinol., August 1, 2007; 157(2): 221 - 223. [Abstract] [Full Text] [PDF]